New Jersey · 2026-2027 Regular Session · Bill

S 2036: Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

In committee Last action January 13, 2026: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Plain-language summary

S 2036 is a bill introduced in the New Jersey Senate on January 13, 2026. According to its official title, it concerns: Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances. Primary sponsor: Vince Polistina (Republican). It lists 1 additional sponsor. Most recent recorded action (January 13, 2026): Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee.

Sponsors

Primary sponsor: Vince Polistina (Republican). 1 co-sponsor.